Intervention Protocol

Antiglucocorticoid and related treatments for psychosis

  1. Belinda Garner1,*,
  2. Lisa Phillips2,
  3. Sarah Bendall3,
  4. Ruth Parslow4,
  5. Sarah E Hetrick5

Editorial Group: Cochrane Schizophrenia Group

Published Online: 23 JAN 2008

DOI: 10.1002/14651858.CD006995


How to Cite

Garner B, Phillips L, Bendall S, Parslow R, Hetrick SE. Antiglucocorticoid and related treatments for psychosis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006995. DOI: 10.1002/14651858.CD006995.

Author Information

  1. 1

    Orygen Youth Health Research Centre, Department of Psychiatry, Melbourne, Victoria, Australia

  2. 2

    University of Melbourne, Psychology, Melbourne, Victoria, Australia

  3. 3

    University of Melbourne, Department of Psychiatry, Melbourne, Victoria, Australia

  4. 4

    University of Melbourne, Australian Centre for Posttraumatic Mental Health, Heidelberg West, Victoria, Australia

  5. 5

    Orygen Youth Health Research Centre; Headspace (The National Youth Mental Health Foundation), Centre of Excellence in Youth Mental Health, Melbourne, Victoria, Australia

*Belinda Garner, Department of Psychiatry, Orygen Youth Health Research Centre, University of Melbourne, Locked Bag 10, 35 Poplar Road, Parkville, Melbourne, Victoria, 3052, Australia. Belinda.Garner@mh.org.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy of antiglucocorticoid and related drugs for the treatment of psychosis, when used alone or in combination with antipsychotic medication.